Increasing cases of alcohol and drugs abuse are a major factor driving the growth of the global alcohol breathalyzer and drugs testing equipment market. Other trends driving growth include single technology devices for alcohol and drugs testing and increasing market share of personal breathalyzers. In addition, stringent government regulations, the emergence of low-cost breathalyzers and growing distribution networks in developing countries are projected to result in increased demand. This, in turn, is expected to bolster alcohol breathalyzer and drugs testing equipment market growth during the forecast period (2015–2020).
This report assesses trends driving each segment and offers analysis and insights about the potential of alcohol breathalyzer and drug testing equipment in specific regions. North America is expected to dominate the market, with a maximum share by the end of 2015. By 2021, North America and Asia-Pacific are expected to collectively contribute over 72.9% revenue to the total global alcohol breathalyzer and drug testing equipment market. In terms of value, Asia-Pacific is estimated to be the fastest-growing market, registering a CAGR of 13.9% during the forecast period.
On the basis of application, the market has been segmented into drugs detection and alcohol detection. By equipment, IR based breathalyzer is expected to remain the largest segment, registering the highest CAGR of 8.9% during the forecast period. The accuracy of such evidential breath testing (EBT) devices is very high, as a result, they are being widely used by federal departments and hospitals. Fuel cell based breathalyzer are expected to register a CAGR of 7.1% during the forecast period. These type of portable devices offer extremely high accuracy concerning blood alcohol content (BAC) and provide instant results. Moreover, such devices require fewer recalibrations as compared to semiconductor-based alcohol breathalyzers. These factors are generating significant demand for fuel-cell based breathalyzers globally.
On the basis of the end user, the market has been segmented into federal departments, hospitals, rehabilitation centers, and private sectors.
On the basis of region, the market has been segmented into North America, Latin America, Europe, Asia-Pacific and the Middle East and Africa.
Downlaod Report Sample @ http://www.persistencemarketresearch.com/samples/3377
“Stories like this, the work behind it and the understanding of the need for it, is something great to think about. Now we should consider the other 65 ingredients, drugs, and synthetics that TOCCA has to manage when helping people.
We all need to work harder, faster and smarter than the producers of drugs or the almost legally evasive recipes of synthetics. After all, everyone knows how much they drink before they hop in a car but no one knows what they are being fed when they buy illicit or synthetic drugs. I think this article displays a great start to understanding the industry”, said Cornell, CEO of TOCCALife.com.